Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

NXP Semiconductors (NXPI) Stock Jumps Again on December 3, 2025: Dividend Rush, AI Tailwinds and Auto Rebound Fuel Rally

NXP Semiconductors (NXPI) Stock Jumps Again on December 3, 2025: Dividend Rush, AI Tailwinds and Auto Rebound Fuel Rally

As of the close on December 3, 2025, NXP Semiconductors N.V. finished at $227.56, up 5.7% on the day and roughly 14% over the last two sessions, after gains of 7.95% on Tuesday.StockAnalysis+1 The move puts the Netherlands‑based chipmaker back near price levels last seen in early autumn, as investors crowd into high‑quality analog and automotive semiconductor names ahead of an important ex‑dividend date and a potentially stronger 2026.
4 December 2025
···
Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

The Goldman Sachs Group, Inc. ended trading on December 3, 2025 around $836–837 per share, near its 52‑week high of $841.28. That gives the Wall Street bank a market capitalization of roughly $260 billion, with a trailing P/E near 17x, forward P/E in the mid‑teens, and dividend yield just under 2%. StockAnalysis+1
3 December 2025
···
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen Inc. is closing out 2025 on a powerful upswing. As of the close on December 3, 2025, Amgen shares finished at $345.42, up about 2% on the day, and nudged higher in after-hours trading.StockAnalysis The move pushed the biotech giant to a fresh 52‑week high near $345.95, extending a year-to-date rally of roughly 35%–37% and a one‑year gain of more than 25%.Investing.com+1
3 December 2025
··
Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

On Wednesday, December 3, 2025, Freeport-McMoRan Inc. closed at $44.53, up 3.63% on the day and comfortably ahead of the broader market, which also posted modest gains. Trading volume hit about 22.8 million shares, above the recent 50‑day average of 20.5 million, underscoring renewed investor interest. Despite the rally, FCX still trades roughly 9.3% below its 52‑week high of $49.12 set on July 8. MarketWatch
3 December 2025
··
D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

As of December 3, 2025, D-Wave Quantum Inc. is again at the center of the quantum-computing story on Wall Street. A new U.S. government-focused business unit, a fresh “Outperform” initiation from Evercore ISI with a $44 price target, and a flurry of valuation debates have turned the stock into one of the most closely watched high‑risk tech names on the market. TS2 Tech+2Quantum Zeitgeist+2
3 December 2025
··
Coca-Cola (KO) Stock on December 3, 2025: Dividend King Faces Lawsuits, Tariffs and M&A Pause as Wall Street Sees Double‑Digit Upside

Coca-Cola (KO) Stock on December 3, 2025: Dividend King Faces Lawsuits, Tariffs and M&A Pause as Wall Street Sees Double‑Digit Upside

The Coca-Cola Company ended trading on December 3, 2025 at $70.81 per share, up 0.2% on the day. That price values the beverage giant at around $304.6 billion in market capitalization and leaves the stock below its 52‑week high of $74.38, with a low‑volatility beta of 0.40 that keeps it firmly in “defensive staple” territory. StockAnalysis+1
3 December 2025
··
Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Inc. remains one of the most closely watched healthcare stocks as of December 3, 2025. The share price is still stuck near post‑COVID lows, but a new $10 billion obesity‑drug acquisition, expanding RSV vaccine markets and a hefty dividend yield around 6.5–7% are reshaping the narrative around the stock. Pfizer+2Pfizer+2
3 December 2025
···
Lam Research (LRCX) Stock on December 3, 2025: AI Chip Boom, Analyst Upgrades and What’s Next for Investors

Lam Research (LRCX) Stock on December 3, 2025: AI Chip Boom, Analyst Upgrades and What’s Next for Investors

Lam Research Corporation, one of the most important suppliers of wafer fabrication equipment to the global semiconductor industry, is ending 2025 in the market spotlight. As of December 3, 2025, Lam Research stock trades around $159.9 per share, valuing the company at roughly $162 billion and implying a trailing price‑to‑earnings ratio of just under 28x.
3 December 2025
·
1 … 843 844 845 846 847 … 890
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 89 / 100
#4 BUY IN TRANCHES

Lennox

NYSE: LII 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.